Skip to content

Clinical trials

Ovarian Neoplasms trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Country / region: New Zealand Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20111
20121
20131
20141
20151
20161
20181
20212
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed4
Terminated3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
AbbVie (prior sponsor, Abbott)1
Amgen1
BeiGene1
Hoosier Cancer Research Network1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1
NHS Greater Glasgow and Clyde1
Pfizer1
Sutro Biopharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms13
Fallopian Tube Neoplasms7
Carcinoma, Ovarian Epithelial4
Breast Neoplasms1
Endometrial Neoplasms1
Peritoneal Neoplasms1
Prostatic Neoplasms1
Small Cell Lung Carcinoma1
Stomach Neoplasms1
Triple Negative Breast Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.